CervoMed Inc. (CRVO)
NCM – Real vaqt narxi. Valyuta: USD
3.77
-0.03 (-0.79%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NCM – Real vaqt narxi. Valyuta: USD
3.77
-0.03 (-0.79%)
Yopilishda: May 12, 2026, 4:00 PM EDT
CervoMed Inc. klinik bosqichdagi biotexnologiya kompaniyasi bo'lib, yoshga bog'liq nevrologik kasalliklarni davolashni ishlab chiqish va tijoratlashtirish bilan shug'ullanadi. Kompaniya qon-miya to'sig'ini kesib o'tuvchi va p38α fermentini ingibitsiya qiluvchi og'iz orqali yuboriladigan kichik molekulali dori bo'lgan neflamapimodni ishlab chiqmoqda. Neflamapimod sinaptik disfunktsiyani tiklash, neyronlarning sog'lig'ini yaxshilash va kasallikning rivojlanishini sekinlashtirish yoki oldini olish salohiyatiga ega. Neflamapimod hozirda Levining tana demansiyasi, birlamchi progressiv afaziyaning nutqsiz varianti, amyotrofik lateral skleroz va amyotrofik lateral sklerozni davolash uchun klinik ishlanmalarda. CervoMed Inc. 2010 yilda tashkil etilgan va shtab-kvartirasi Boston, Massachusetsda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Claudia Ordonez M.D. | Senior Vice President of Medical Science |
| Dr. John J. Alam M.D. | Co-Founder, CEO, President & Director |
| Dr. Marinus Verwijs Ph.D. | Executive Vice President of Technical Operations |
| Dr. Mark A. De Rosch Ph.D. | Executive VP of Regulatory, Government Affairs & Program Management |
| Dr. Matthew Winton Ph.D. | Chief Commercial & Business Officer |
| Dr. Sylvie L. Gregoire Pharm.D. | Co-Founder & Director |
| Mr. William Robert Elder J.D. | CFO, General Counsel & Corporate Secretary |
| Ms. Kelly Blackburn M.H.A. | Executive Vice President of Clinical Development |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-30 | DEF 14A | crvo20260428_def14a.htm |
| 2026-04-22 | 8-K | crvo20260422_8k.htm |
| 2026-04-07 | 8-K | crvo20260407_8k.htm |
| 2026-03-23 | 8-K | crvo20260323_8k.htm |
| 2026-03-19 | 8-K | crvo20260319_8k.htm |
| 2026-03-17 | 8-K | crvo20260317_8k.htm |
| 2026-03-13 | 10-K | crvo20251231_10k.htm |
| 2026-03-04 | 8-K | crvo20260304_8k.htm |
| 2026-02-18 | 8-K | crvo20260218_8k.htm |
| 2026-01-08 | 8-K | crvo20260108_8k.htm |